Novelties in dosage form design of the cardiovascular drugs

Contemporary trends in dosage form development for cardiovascular therapeutics are orientated toward rationalization and individualization of drug administration with the achievement of good compliance. Therefore, novelties in formulation development of cardiovascular drugs are directed towards the modified drug delivery systems. There is a number and variety of new technologies employed with this respect. In the present paper, and overview of the most important technologies applied in commercially available drug products within the group of cardiovascular drugs is given, such as extended release tablets/capsules, multiparticulate drug delivery systems, pulsatile drug delivery and OrosTM technology.